Calendar

A Science & Innovation Webinar, presented by Jazz Pharmaceuticals.

This webinar will explore the role of HER2 as an actionable biomarker in Biliary tract cancer (BTC), and highlight recent clinical data supporting HER2-targeted therapies. Managed care professionals will gain insights into the evolving treatment landscape, the importance of timely access to molecular testing and therapy, and strategies to optimize coverage decisions. Join us for a timely discussion on how managed care professionals can support improved outcomes for patients with HER2-positive BTC.

A Science & Innovation Webinar, presented by Abbvie.

Many patients require augmentation of their antidepressant with an additional therapy, and augmentation with an atypical antipsychotic is a guideline-recommended option for appropriate Major Depressive Disorder (MDD) patients. This session will focus on the burden of MDD and the impact of an atypical antipsychotic approved for the adjunctive treatment of MDD.

A Science & Innovation Webinar, presented by Abbvie.

Vitiligo is more than a cosmetic concern. It is a chronic, autoimmune disease characterized by the progressive loss of melanocytes, leading to depigmented patches on the skin—the body’s most visible and socially expressive organ. NSV reflects underlying immune dysregulation and can be associated with systemic comorbidities such as autoimmune thyroid disease, type 1 diabetes, pernicious anemia, and alopecia areata. Beyond the physical manifestations, NSV carries a profound psychological burden, with increased rates of anxiety, depression, and social withdrawal. These interconnected challenges not only affect patient quality of life but also contribute to broader healthcare utilization and underscore the need for holistic, long-term management strategies.

An AMCP Member Webinar

A Science & Innovation Webinar, presented by Abbvie.

One of the primary goals of acute treatment of migraine is rapid and consistent freedom from pain and associated symptoms without recurrence. Regardless of migraine frequency or time of month, it is important that every appropriate person with migraine be offered a migraine-specific treatment. The objective for this webinar is to review the migraine disease state and outline the clinical data for an acute treatment of migraine including data for perimenstrual attacks.